Endocrinology, Diabetes & Metabolism Case Reports is an essential information resource designed to further both medical education and clinical practice by publishing and linking together case reports on common and rare conditions in all areas of clinical endocrinology, diabetes and metabolism.
Endocrinology, Diabetes & Metabolism Case Reports is indexed in PubMed, PubMed Central, Sherpa/ROMEO, EMBASE, Emerging Sources Citation Index and the Directory of Open Access Journals. Please note that on publication of a manuscript, author data is transferred to these services. This includes all authors names and affiliations and the email address of the corresponding author.
It is an online-only, open-access resource with very reasonable publication fees – all case reports are freely available online to everyone across the world. Practitioners are able to communicate findings, share knowledge and convey medical experiences efficiently and effectively across the many disciplines intersecting with endocrinology, diabetes and metabolism.
Our esteemed Editorial Board, dedicated in-house support and rigorous peer-review process ensure high-quality content and rapid publishing times. The Editorial Board consider articles reporting unusual symptoms, novel treatments and key findings that shed new light on the possible pathogenesis of a disease. Whilst the scope is broad, articles must present clear learning points which readers can apply to medical education or clinical practice.
Endocrinology, Diabetes & Metabolism Case Reports’ sophisticated classification, search and browse functionality allows users to find and navigate between cases with ease and efficiency in order to spot trends and contradictions, making it the go-to resource for everyone working in all areas of endocrinology, diabetes and metabolism.
Endocrinology, Diabetes & Metabolism Case Reports is published by Bioscientifica.
Endocrinology, Diabetes & Metabolism Case Reports is unique in bringing together international and national endocrinology, diabetes and metabolism societies to collaborate on this publication in order to benefit those societies, their members and the community as a whole. One of these benefits is that members of collaborating societies enjoy a discount on the publishing fees. View our endorsing societies.
Dr. Maralyn Druce - Reader in Endocrine Medicine and Consultant in Endocrinology, Barts and the London Medical School, London
Dr. Jennifer Green - Associate Professor of Medicine, Division of Endocrinology, Metabolism and Nutrition, Duke University Medical Center and Duke Clinical Research Institute, North Carolina, USA
Prof. Jerry Greenfield - Associate Professor, Head of the Department of Endocrinology and Deputy Director of the Diabetes Services at St Vincent’s Hospital, Sydney, Australia
View the full Editorial Board.
Endocrinology, Diabetes & Metabolism Case Reports is an open-access publication, providing authors with rapid dissemination of their work and ensuring that readers have free, unrestricted and immediate access to the latest high-quality, peer-reviewed case reports. The costs of publication are covered by a publishing fee payable by authors (or their funding body or institution) upon acceptance.
*VAT (Value Added Tax) will be added to transactions within the UK and Europe.
Articles are published under the terms of the Creative Attribution-NonCommercial-NoDerivs 3.0 Unported License (CC BY-NC-ND 3.0). Authors also grant Bioscientifica Ltd (the publisher) commercial rights.
Published articles are fully referenced and linked to a wide variety of discoverability services. Endocrinology, Diabetes & Metabolism Case Reports is indexed in PubMed, PubMed Central, Sherpa/ROMEO, EMBASE, Emerging Sources Citation Index and the Directory of Open Access Journals. We anticipate future indexing by Medline, which will be applied to all published articles retrospectively.
Research journal editorial policies usually restrict all but a few (if any) case reports being published so as not to waste valuable space or stunt impact factor growth. As case reports are not highly cited (despite being widely read), we do not expect this publication to be considered for an impact factor by Thomson Reuters. Rather, Endocrinology, Diabetes & Metabolism Case Reports will provide a welcome publishing outlet for authors’ case reports, and will not be restricting the number of high-quality case reports published.
Endocrinology, Diabetes & Metabolism Case Reports is committed to integrity in research. In order to ensure that the publication’s contribution to the scientific record is reliable and meets the ethical standards expected by the global scientific community, we have developed a code of ethics to support editors, authors and peer reviewers in understanding the standards of behaviour they should follow in carrying out their roles in the publishing process. View our ethical policy.